Mymetics Corporation (MYMX)
Sector • Healthcare Industry • Biotechnology & Pharmaceuticals |
Industry • Biotechnology & Pharmaceuticals |
Sector • Healthcare |
News
Mymetics Corporation Faces Challenging Performance in Q3 2023 as Earnings Decline
Top-line was $0.1456 millions at the Mymetics Corporation in the third quarter of 2022
Mymetics Corporation reported Revenue of $0.33264 million, in the most recent fiscal period
MYMX during the financial interval ending December 31 2021